527 related articles for article (PubMed ID: 16426869)
81. Levetiracetam add-on therapy in Japanese patients with refractory partial epilepsy.
Tanaka S; Tanaka T
Epileptic Disord; 2013 Jun; 15(2):132-41. PubMed ID: 23774199
[TBL] [Abstract][Full Text] [Related]
82. [Non-convulsive epileptic status reverted with intravenous levetiracetam].
Callén-Soto A; Pérez-Pérez S; Robles-Del Olmo B
Rev Neurol; 2008 Nov 1-15; 47(9):501-2. PubMed ID: 18985603
[No Abstract] [Full Text] [Related]
83. Neonatal status epilepticus controlled with levetiracetam at Sturge Weber syndrome.
Tanriverdi S; Terek D; Koroglu OA; Yalaz M; Tekgul H; Kultursay N
Brain Dev; 2013 Apr; 35(4):367-71. PubMed ID: 22804835
[TBL] [Abstract][Full Text] [Related]
84. Effect of levetiracetam in patients with epilepsy and interictal epileptiform discharges.
Stodieck S; Steinhoff BJ; Kolmsee S; van Rijckevorsel K
Seizure; 2001 Dec; 10(8):583-7. PubMed ID: 11792161
[TBL] [Abstract][Full Text] [Related]
85. Status epilepticus induction has prolonged effects on the efficacy of antiepileptic drugs in the 6-Hz seizure model.
Leclercq K; Kaminski RM
Epilepsy Behav; 2015 Aug; 49():55-60. PubMed ID: 26123104
[TBL] [Abstract][Full Text] [Related]
86. Efficacy Of Levetiracetam Versus Phenytoin As A Second-Line Antiepileptic Drug In The Management Of Benzodiazepine-Refractory Status Epilepticus Among Children.
Naeem B; Ashfaq M; Qureshi MA
J Ayub Med Coll Abbottabad; 2023; 35(3):410-414. PubMed ID: 38404082
[TBL] [Abstract][Full Text] [Related]
87. Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy.
Glien M; Brandt C; Potschka H; Löscher W
Epilepsia; 2002 Apr; 43(4):350-7. PubMed ID: 11952764
[TBL] [Abstract][Full Text] [Related]
88. Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures.
Baulac M; Brodie MJ; Elger CE; Krakow K; Stockis A; Meyvisch P; Falter U
Epilepsia; 2007 Mar; 48(3):589-92. PubMed ID: 17326794
[TBL] [Abstract][Full Text] [Related]
89. A prehospital randomized trial in convulsive status epilepticus.
Navarro V; Dagron C; Demeret S; An K; Lamhaut L; Bolgert F; Baulac M; Carli P
Epilepsia; 2011 Oct; 52 Suppl 8():48-9. PubMed ID: 21967362
[TBL] [Abstract][Full Text] [Related]
90. Continuous subcutaneous use of levetiracetam: a retrospective review of tolerability and clinical effects.
Rémi C; Lorenzl S; Vyhnalek B; Rastorfer K; Feddersen B
J Pain Palliat Care Pharmacother; 2014 Dec; 28(4):371-7. PubMed ID: 25313924
[TBL] [Abstract][Full Text] [Related]
91. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M
Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
[TBL] [Abstract][Full Text] [Related]
92. Oral topiramate as an add-on treatment for refractory status epilepticus.
Stojanova V; Rossetti AO
Acta Neurol Scand; 2012 Feb; 125(2):e7-e11. PubMed ID: 21711264
[TBL] [Abstract][Full Text] [Related]
93. Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials.
Gidal BE; Baltès E; Otoul C; Perucca E
Epilepsy Res; 2005; 64(1-2):1-11. PubMed ID: 15823510
[TBL] [Abstract][Full Text] [Related]
94. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
[TBL] [Abstract][Full Text] [Related]
95. Intravenous levetiracetam: treatment experience with the first 50 critically ill patients.
Rüegg S; Naegelin Y; Hardmeier M; Winkler DT; Marsch S; Fuhr P
Epilepsy Behav; 2008 Apr; 12(3):477-80. PubMed ID: 18291724
[TBL] [Abstract][Full Text] [Related]
96. Levetiracetam (keppra) in the treatment of refractory status epilepticus.
Zenkov LR; Shevtsov KI; Gubanova NB
Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(5):71-4. PubMed ID: 18688957
[No Abstract] [Full Text] [Related]
97. Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study.
Garcés M; Villanueva V; Mauri JA; Suller A; García C; López González FJ; Rodríguez Osorio X; Fernández Pajarín G; Piera A; Guillamón E; Santafé C; Castillo A; Giner P; Torres N; Escalza I; Del Villar A; García de Casasola MC; Bonet M; Noé E; Olmedilla N
Epilepsy Behav; 2014 Jul; 36():144-52. PubMed ID: 24922617
[TBL] [Abstract][Full Text] [Related]
98. Treatment and course of different subtypes of status epilepticus.
Rantsch K; Walter U; Wittstock M; Benecke R; Rösche J
Epilepsy Res; 2013 Nov; 107(1-2):156-62. PubMed ID: 24016689
[TBL] [Abstract][Full Text] [Related]
99. Double-masked, placebo-controlled study of intravenous levetiracetam for the treatment of status epilepticus and acute repetitive seizures in dogs.
Hardy BT; Patterson EE; Cloyd JM; Hardy RM; Leppik IE
J Vet Intern Med; 2012; 26(2):334-40. PubMed ID: 22295898
[TBL] [Abstract][Full Text] [Related]
100. [Therapeutic effects of levetiracetam on electrical status epilepticus during sleep in children].
Zhang WN; Zou LP; Ju J; Li XY
Zhongguo Dang Dai Er Ke Za Zhi; 2012 May; 14(5):340-3. PubMed ID: 22613103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
